Detailed answers about IMMUNEPEPTIDES LIMITED, including incorporation, status, business activity, and accounts information.
When was IMMUNEPEPTIDES LIMITED founded?
IMMUNEPEPTIDES LIMITED was officially incorporated on 27 August 2008 and is registered under company number 06681631. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is IMMUNEPEPTIDES LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of IMMUNEPEPTIDES LIMITED?
IMMUNEPEPTIDES LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does IMMUNEPEPTIDES LIMITED do?
IMMUNEPEPTIDES LIMITED operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is IMMUNEPEPTIDES LIMITED's registered address?
The registered office address of IMMUNEPEPTIDES LIMITED is 24 SERPENTINE ROAD, HARBORNE, BIRMINGHAM, B17 9RE. This is the official address filed with Companies House for legal and statutory correspondence.
Is IMMUNEPEPTIDES LIMITED financially stable?
The most recent accounts for IMMUNEPEPTIDES LIMITED were made up to 30 September 2024, filed as MICRO ENTITY. Next accounts are due by 30 June 2026.